Estimating Central Pulse Pressure From Blood Flow by Identifying the Main Physical Determinants of Pulse Pressure Amplification.

1-D model analytical solutions central pressure hemodynamics peripheral pressure pulse pressure amplification

Journal

Frontiers in physiology
ISSN: 1664-042X
Titre abrégé: Front Physiol
Pays: Switzerland
ID NLM: 101549006

Informations de publication

Date de publication:
2021
Historique:
received: 18 09 2020
accepted: 18 01 2021
entrez: 12 3 2021
pubmed: 13 3 2021
medline: 13 3 2021
Statut: epublish

Résumé

Several studies suggest that central (aortic) blood pressure (cBP) is a better marker of cardiovascular disease risk than peripheral blood pressure (pBP). The morphology of the pBP wave, usually assessed non-invasively in the arm, differs significantly from the cBP wave, whose direct measurement is highly invasive. In particular, pulse pressure, PP (the amplitude of the pressure wave), increases from central to peripheral arteries, leading to the so-called pulse pressure amplification (ΔPP). The main purpose of this study was to develop a methodology for estimating central PP (cPP) from non-invasive measurements of aortic flow and peripheral PP. Our novel approach is based on a comprehensive understanding of the main cardiovascular properties that determine ΔPP along the aortic-brachial arterial path, namely brachial flow wave morphology in late systole, and vessel radius and distance along this arterial path. This understanding was achieved by using a blood flow model which allows for workable analytical solutions in the frequency domain that can be decoupled and simplified for each arterial segment. Results show the ability of our methodology to (i) capture changes in cPP and ΔPP produced by variations in cardiovascular properties and (ii) estimate cPP with mean differences smaller than 3.3 ± 2.8 mmHg on

Identifiants

pubmed: 33708133
doi: 10.3389/fphys.2021.608098
pmc: PMC7940670
doi:

Types de publication

Journal Article

Langues

eng

Pagination

608098

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : British Heart Foundation
ID : PG/15/104/31913
Pays : United Kingdom
Organisme : British Heart Foundation
ID : SP/14/8/31352
Pays : United Kingdom

Informations de copyright

Copyright © 2021 Flores Gerónimo, Corvera Poiré, Chowienczyk and Alastruey.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Hypertension. 2002 Mar 1;39(3):735-8
pubmed: 11897754
Hypertension. 2009 Aug;54(2):375-83
pubmed: 19564542
Ann Biomed Eng. 2016 Oct;44(10):3047-3068
pubmed: 27138525
Circulation. 2006 Mar 7;113(9):1213-25
pubmed: 16476843
Hypertension. 2019 May;73(5):1018-1024
pubmed: 30929514
Hypertension. 1996 Feb;27(2):168-75
pubmed: 8567037
IEEE Trans Inf Technol Biomed. 2012 Mar;16(2):212-20
pubmed: 22147332
Postgrad Med J. 2007 Feb;83(976):109-14
pubmed: 17308214
Am J Hypertens. 2013 Jan;26(1):20-6
pubmed: 23382323
Hypertension. 2017 Feb;69(2):375-381
pubmed: 27920128
Hypertension. 2010 Nov;56(5):926-33
pubmed: 20876451
Am J Physiol. 1995 Oct;269(4 Pt 2):H1363-9
pubmed: 7485569
Am J Physiol Heart Circ Physiol. 2019 Nov 1;317(5):H1062-H1085
pubmed: 31442381
Am J Physiol Heart Circ Physiol. 2014 May 15;306(10):H1408-16
pubmed: 24705557
Hypertension. 2017 Dec;70(6):1176-1182
pubmed: 29084874
Eur Heart J. 2017 Oct 1;38(37):2805-2812
pubmed: 28158489
Hypertension. 2013 Dec;62(6):1138-45
pubmed: 24060891
World J Nephrol. 2016 Jan 6;5(1):90-100
pubmed: 26788468
J R Soc Interface. 2018 Dec 21;15(149):20180546
pubmed: 30958234
J Physiol. 2016 Apr 15;594(8):2275-84
pubmed: 26140618
Am J Hypertens. 2002 Jan;15(1 Pt 1):24-30
pubmed: 11824855
Hypertension. 2007 Jul;50(1):154-60
pubmed: 17562972
Chest. 1992 Oct;102(4):1193-8
pubmed: 1395767
Clin Exp Hypertens. 1997 Jul-Aug;19(5-6):793-811
pubmed: 9247756
Hypertension. 2001 Dec 1;38(6):1461-6
pubmed: 11751736
Hypertension. 2014 May;63(5):1050-5
pubmed: 24516104
Am J Physiol Heart Circ Physiol. 2009 Nov;297(5):H1956-63
pubmed: 19783780
Hypertension. 2014 Nov;64(5):1116-23
pubmed: 25156172
Sci Rep. 2016 Sep 14;6:33230
pubmed: 27624389
Cardiovasc Res. 1970 Jul;4(3):291-300
pubmed: 5480717
J Biomech. 1992 Nov;25(11):1337-49
pubmed: 1400535
Ann Biomed Eng. 2015 Jun;43(6):1443-60
pubmed: 25832485
Hypertension. 2000 Feb;35(2):637-42
pubmed: 10679510
Am J Hypertens. 2011 Dec;24(12):1312-7
pubmed: 21850061
Eur Heart J. 2014 Jul;35(26):1719-25
pubmed: 24459197
Sci Rep. 2017 Oct 31;7(1):14441
pubmed: 29089581
Eur Heart J. 2014 Nov 21;35(44):3122-33
pubmed: 25112663
Physiol Meas. 2004 Aug;25(4):879-89
pubmed: 15382828
Hypertens Res. 2018 Jun;41(6):444-450
pubmed: 29540825
Am J Physiol Heart Circ Physiol. 2017 Sep 1;313(3):H558-H567
pubmed: 28576835
J Hypertens. 2018 Oct;36(10):1953-2041
pubmed: 30234752
Blood Press. 2016;25(1):21-7
pubmed: 26414776
Hypertension. 2009 Aug;54(2):414-20
pubmed: 19546377

Auteurs

Joaquín Flores Gerónimo (J)

Department of Biomedical Engineering, School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom.

Eugenia Corvera Poiré (E)

Departamento de Física y Química Teórica, Facultad de Química, Universidad Nacional Autónoma de México, Ciudad Universitaria, Mexico City, Mexico.
Universitat de Barcelona Institute of Complex Systems (UBICS), Universitat de Barcelona, Barcelona, Spain.

Philip Chowienczyk (P)

Department of Clinical Pharmacology, British Heart Foundation Centre, St Thomas' Hospital, King's College London, London, United Kingdom.

Jordi Alastruey (J)

Department of Biomedical Engineering, School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom.
World-Class Research Center, Digital Biodesign and Personalized Healthcare, Sechenov University, Moscow, Russia.

Classifications MeSH